| Literature DB >> 27769673 |
Shawn I Walsh1, Arryn Craney1, Floyd E Romesberg1.
Abstract
The looming antibiotic crisis has prompted the development of new strategies towards fighting infection. Traditional antibiotics target bacterial processes essential for viability, whereas proposed antivirulence approaches rely on the inhibition of factors that are required only for the initiation and propagation of infection within a host. Although antivirulence compounds have yet to prove their efficacy in the clinic, bacterial signal peptidase I (SPase) represents an attractive target in that SPase inhibitors exhibit broad-spectrum antibiotic activity, but even at sub-MIC doses also impair the secretion of essential virulence factors. The potential consequences of SPase inhibition on bacterial virulence have not been thoroughly examined, and are explored within this review. In addition, we review growing evidence that SPase has relevant biological functions outside of mediating secretion, and discuss how the inhibition of these functions may be clinically significant. Copyright ÂEntities:
Keywords: Antivirulence; Arylomycin; Protein translocation; SPase; Secretion
Mesh:
Substances:
Year: 2016 PMID: 27769673 PMCID: PMC5279723 DOI: 10.1016/j.bmc.2016.09.048
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641